|
Third Wave Technologies, Inc. - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Third Wave Technologies, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Third Wave Technologies, Inc.. The Group's principal activities are to develops and markets molecular diagnostics for a variety of DNA and RNA analysis applications, providing its clinical, research and agricultural customers with superior molecular solutions. Our products are based on our proprietary Invader chemistry. The Group coverts it's proprietary Invader(R) molecular chemistry into valuable molecular diagnostic products. These products have applications in genetics and pharmacogenetics, women's health, infectious disease and oncology etc and it has been extended to research, agricultural and other applications also. The Group markets and sells products through a combination of direct sales personnel and through collaborative relationships. Its registered trademarks are Third Wave(R), Cleavase(R), Invader(R), InvaderCreator(R) and Invader Plus(R). The Group has operations in the United States, Japan, Germany, France and the United Kingdom.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
